However, most patients fail to respond or relapse and outcomes after HMA-based therapy remain poor, with limited effective options ...Table 1 ... ADVANCED MYELODYSPLASTIC NEOPLASMS OR AML FAILING HMA-BASED THERAPY - PRELIMINARY RESULTS OF THE IMPRESS STUDY.
HMAAgro Industries shares rose 10% after reporting a 68% YoY profit increase to ₹89.76 crore for Q2FY26. Sales surged 47% to ₹2155.34 crore. The stock remains 30% below its 52-week high but has gained 8% over the past month ....